China Cardiac Biomarkers Market Report & Forecast 2021-2027

Publisher Name :
Date: 22-Dec-2021
No. of pages: 91
Inquire Before Buying

China Cardiac Biomarkers Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Cardiac Biomarkers Market Segment Percentages, By Type, 2020 (%)

- Troponin

- CK-MB

- Natriuretic Peptides - BNP and NT-proBNP

- Myoglobin

- Others

China Cardiac Biomarkers Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Cardiac Biomarkers Market Segment Percentages, By Application, 2020 (%)

- Acute Coronary Syndrome

- Myocardial Infarction

- Congestive Heart Failure

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cardiac Biomarkers revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Cardiac Biomarkers revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Abbott

- Abbott

- F. Hoffmann-La Roche

- Advanced ImmunoChemical

- AgPlus Diagnostics

- BG Medicine

- BioLegend

- bioMérieux

- Bio-Rad Laboratories

- BODITECH MED

China Cardiac Biomarkers Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cardiac Biomarkers Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Cardiac Biomarkers Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Cardiac Biomarkers Overall Market Size
2.1 China Cardiac Biomarkers Market Size: 2021 VS 2027
2.2 China Cardiac Biomarkers Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiac Biomarkers Players in China Market
3.2 Top China Cardiac Biomarkers Companies Ranked by Revenue
3.3 China Cardiac Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Cardiac Biomarkers Companies in China Market, by Revenue in 2020
3.5 Companies Cardiac Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiac Biomarkers Players in China Market
3.6.1 List of Tier 1 Cardiac Biomarkers Companies in China
3.6.2 List of Tier 2 and Tier 3 Cardiac Biomarkers Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Cardiac Biomarkers Market Size Markets, 2021 & 2027
4.1.2 Troponin
4.1.3 CK-MB
4.1.4 Natriuretic Peptides - BNP and NT-proBNP
4.1.5 Myoglobin
4.1.6 Others
4.2 By Type - China Cardiac Biomarkers Revenue & Forecasts
4.2.1 By Type - China Cardiac Biomarkers Revenue, 2016-2021
4.2.2 By Type - China Cardiac Biomarkers Revenue, 2022-2027
4.2.3 By Type - China Cardiac Biomarkers Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Cardiac Biomarkers Market Size, 2021 & 2027
5.1.2 Acute Coronary Syndrome
5.1.3 Myocardial Infarction
5.1.4 Congestive Heart Failure
5.1.5 Others
5.2 By Application - China Cardiac Biomarkers Revenue & Forecasts
5.2.1 By Application - China Cardiac Biomarkers Revenue, 2016-2021
5.2.2 By Application - China Cardiac Biomarkers Revenue, 2022-2027
5.2.3 By Application - China Cardiac Biomarkers Revenue Market Share, 2016-2027
6 Cardiac Biomarkers Companies Profiles
6.1 Abbott
6.1.1 Abbott Company Details
6.1.2 Abbott Business Overview
6.1.3 Abbott Cardiac Biomarkers Introduction
6.1.4 Abbott Cardiac Biomarkers Revenue in China Market (2016-2021)
6.1.5 Abbott Recent Developments
6.2 Abbott
6.2.1 Abbott Company Details
6.2.2 Abbott Business Overview
6.2.3 Abbott Cardiac Biomarkers Introduction
6.2.4 Abbott Cardiac Biomarkers Revenue in China Market (2016-2021)
6.2.5 Abbott Recent Developments
6.3 F. Hoffmann-La Roche
6.3.1 F. Hoffmann-La Roche Company Details
6.3.2 F. Hoffmann-La Roche Business Overview
6.3.3 F. Hoffmann-La Roche Cardiac Biomarkers Introduction
6.3.4 F. Hoffmann-La Roche Cardiac Biomarkers Revenue in China Market (2016-2021)
6.3.5 F. Hoffmann-La Roche Recent Developments
6.4 Advanced ImmunoChemical
6.4.1 Advanced ImmunoChemical Company Details
6.4.2 Advanced ImmunoChemical Business Overview
6.4.3 Advanced ImmunoChemical Cardiac Biomarkers Introduction
6.4.4 Advanced ImmunoChemical Cardiac Biomarkers Revenue in China Market (2016-2021)
6.4.5 Advanced ImmunoChemical Recent Developments
6.5 AgPlus Diagnostics
6.5.1 AgPlus Diagnostics Company Details
6.5.2 AgPlus Diagnostics Business Overview
6.5.3 AgPlus Diagnostics Cardiac Biomarkers Introduction
6.5.4 AgPlus Diagnostics Cardiac Biomarkers Revenue in China Market (2016-2021)
6.5.5 AgPlus Diagnostics Recent Developments
6.6 BG Medicine
6.6.1 BG Medicine Company Details
6.6.2 BG Medicine Business Overview
6.6.3 BG Medicine Cardiac Biomarkers Introduction
6.6.4 BG Medicine Cardiac Biomarkers Revenue in China Market (2016-2021)
6.6.5 BG Medicine Recent Developments
6.7 BioLegend
6.7.1 BioLegend Company Details
6.7.2 BioLegend Business Overview
6.7.3 BioLegend Cardiac Biomarkers Introduction
6.7.4 BioLegend Cardiac Biomarkers Revenue in China Market (2016-2021)
6.7.5 BioLegend Recent Developments
6.8 bioMérieux
6.8.1 bioMérieux Company Details
6.8.2 bioMérieux Business Overview
6.8.3 bioMérieux Cardiac Biomarkers Introduction
6.8.4 bioMérieux Cardiac Biomarkers Revenue in China Market (2016-2021)
6.8.5 bioMérieux Recent Developments
6.9 Bio-Rad Laboratories
6.9.1 Bio-Rad Laboratories Company Details
6.9.2 Bio-Rad Laboratories Business Overview
6.9.3 Bio-Rad Laboratories Cardiac Biomarkers Introduction
6.9.4 Bio-Rad Laboratories Cardiac Biomarkers Revenue in China Market (2016-2021)
6.9.5 Bio-Rad Laboratories Recent Developments
6.10 BODITECH MED
6.10.1 BODITECH MED Company Details
6.10.2 BODITECH MED Business Overview
6.10.3 BODITECH MED Cardiac Biomarkers Introduction
6.10.4 BODITECH MED Cardiac Biomarkers Revenue in China Market (2016-2021)
6.10.5 BODITECH MED Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Cardiac Biomarkers Market Opportunities & Trends in China Market
Table 2. Cardiac Biomarkers Market Drivers in China Market
Table 3. Cardiac Biomarkers Market Restraints in China Market
Table 4. Key Players of Cardiac Biomarkers in China Market
Table 5. Top Cardiac Biomarkers Players in China Market, Ranking by Revenue (2019)
Table 6. China Cardiac Biomarkers Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Cardiac Biomarkers Revenue Share by Companies, 2016-2021
Table 8. Companies Cardiac Biomarkers Product Type
Table 9. List of Tier 1 Cardiac Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cardiac Biomarkers Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Cardiac Biomarkers Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Cardiac Biomarkers Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Cardiac Biomarkers Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Cardiac Biomarkers Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Cardiac Biomarkers Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Cardiac Biomarkers Revenue (US$, Mn), 2022-2027
Table 17. Abbott Company Details
Table 18. Abbott Business Overview
Table 19. Abbott Cardiac Biomarkers Product
Table 20. Abbott Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Abbott Recent Developments
Table 22. Abbott Company Details
Table 23. Abbott Business Overview
Table 24. Abbott Cardiac Biomarkers Product
Table 25. Abbott Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Abbott Recent Developments
Table 27. F. Hoffmann-La Roche Company Details
Table 28. F. Hoffmann-La Roche Business Overview
Table 29. F. Hoffmann-La Roche Cardiac Biomarkers Product
Table 30. F. Hoffmann-La Roche Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 31. F. Hoffmann-La Roche Recent Developments
Table 32. Advanced ImmunoChemical Company Details
Table 33. Advanced ImmunoChemical Business Overview
Table 34. Advanced ImmunoChemical Cardiac Biomarkers Product
Table 35. Advanced ImmunoChemical Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Advanced ImmunoChemical Recent Developments
Table 37. AgPlus Diagnostics Company Details
Table 38. AgPlus Diagnostics Business Overview
Table 39. AgPlus Diagnostics Cardiac Biomarkers Product
Table 40. AgPlus Diagnostics Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 41. AgPlus Diagnostics Recent Developments
Table 42. BG Medicine Company Details
Table 43. BG Medicine Business Overview
Table 44. BG Medicine Cardiac Biomarkers Product
Table 45. BG Medicine Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 46. BG Medicine Recent Developments
Table 47. BioLegend Company Details
Table 48. BioLegend Business Overview
Table 49. BioLegend Cardiac Biomarkers Product
Table 50. BioLegend Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 51. BioLegend Recent Developments
Table 52. bioMérieux Company Details
Table 53. bioMérieux Business Overview
Table 54. bioMérieux Cardiac Biomarkers Product
Table 55. bioMérieux Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 56. bioMérieux Recent Developments
Table 57. Bio-Rad Laboratories Company Details
Table 58. Bio-Rad Laboratories Business Overview
Table 59. Bio-Rad Laboratories Cardiac Biomarkers Product
Table 60. Bio-Rad Laboratories Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Bio-Rad Laboratories Recent Developments
Table 62. BODITECH MED Company Details
Table 63. BODITECH MED Business Overview
Table 64. BODITECH MED Cardiac Biomarkers Product
Table 65. BODITECH MED Cardiac Biomarkers Revenue in China Market (2016-2021) & (US$ Million)
Table 66. BODITECH MED Recent Developments
List of Figures
Figure 1. Cardiac Biomarkers Segment by Type
Figure 2. Cardiac Biomarkers Segment by Application
Figure 3. China Cardiac Biomarkers Market Overview: 2020
Figure 4. China Cardiac Biomarkers Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Cardiac Biomarkers Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Cardiac Biomarkers Revenue in 2020
Figure 7. By Type - China Cardiac Biomarkers Revenue Market Share, 2016-2027
Figure 8. By Application - China Cardiac Biomarkers Revenue Market Share, 2016-2027
Figure 9. Abbott Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Abbott Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. F. Hoffmann-La Roche Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Advanced ImmunoChemical Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. AgPlus Diagnostics Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. BG Medicine Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. BioLegend Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. bioMérieux Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Bio-Rad Laboratories Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. BODITECH MED Cardiac Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Biomarkers Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biomarkers market size was valued at US$ 61570 million in 2023. With growing demand in downstream market, the Biomarkers is forecast to a readjusted size of US$ 165240 million by 2030 with a CAGR of 15.1% during review period. The research report highlights the growth potential of the global Biomarkers market. Biomarkers are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Biomarker (Medicine) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Biomarker (Medicine) market: According to our latest research, the global Biomarker (Medicine) market looks promising in the next 5 years. As of 2022, the global Biomarker (Medicine) market was estimated at USD 54332.95 million, and it's anticipated to reach USD 82760.29 million in 2028, with a CAGR of 7.27% during the forecast years. Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker i......
  • Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications market size was valued at US$ 20920 million in 2023. With growing demand in downstream market, the Commercializing Biomarkers in Therapeutic and Diagnostic Applications is forecast to a readjusted size of US$ 29400 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Commercializing Biom......
  • Global Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Biomarkers market: According to our latest research, the global Biomarkers market looks promising in the next 5 years. As of 2022, the global Biomarkers market was estimated at USD 76755.97 million, and it's anticipated to reach USD 184776.75 million in 2028, with a CAGR of 15.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biomarkers market, with a......
  • Global Biomarker Technology Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomarker Technology market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Quanterix - Bio-Rad Laboratories - Epigenomics - Agilent Technologies - Johnson & Johnson - Qiagen - Roche Ho......
  • Global Renal Biomarkers Market Research Report 2023
    Published: 01-Dec-2023        Price: US 2900 Onwards        Pages: 99
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Diagnostics - F. Hoffmann-La Roche - Beckman Coulter - Siemens Healthcare Diagnostics - Thermo Fisher Scientific - Astute Medical - Bio......
  • Global Central Nervous System (CNS) Biomarkers Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Central Nervous System (CNS) Biomarkers market: According to our latest research, the global Central Nervous System (CNS) Biomarkers market looks promising in the next 5 years. As of 2022, the global Central Nervous System (CNS) Biomarkers market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. An overview of the global market for central nervous system (CNS) biomarke......
  • Global Cancer Biomarker Market Research Report 2023
    Published: 13-Nov-2023        Price: US 2900 Onwards        Pages: 109
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Biomarker market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Thermo Fisher Scientific - Bio-Rad Laboratories - Roche Diagnostics - Qiagen - Illumina - GE Healthcare - Agilent Technologies - Biomér......
  • Biomarker Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Biomarker Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the biomarker deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of biomarker deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter biomarker deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercializ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs